Transdermal administration of (2S) - (4E) -N-methyl-5- (3- ( 5-is0pr0p0xypyridin) yl) - 4-penten-2-amine

Details for Australian Patent Application No. 2008282205 (hide)

International Classifications

Event Publications

25 February 2010 PCT application entered the National Phase

PCT publication WO2009/018373 Priority application(s): WO2009/018373

4 March 2010 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name AstraZeneca AB and Targacept, Inc., Application No. 2008282205, under INID (54) correct the title to read Transdermal administration of (2S)-(4E)-N-methyl-5-(3-( 5-isopropoxypyridin)yl)-4-penten-2-amine.

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.